Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

NCT01202695 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Anthrax

Interventions

DRUG: AVP-21D9
DRUG: Placebo

Sponsor

Emergent BioSolutions

Collaborators

[object Object]